Reduction of the rectal dose in gynecological brachytherapy: modification to the Fletcher-Suit applicator.
The dose to the anterior rectal wall is a known limiting factor for the delivery of radical doses of radiation to the uterine cervix with brachytherapy. We developed a modification to the Fletcher-Suit afterloading applicator, consisting of two small inflatable balloons attached to the posterior end of each colpostat. The balloons are connected to catheters that emerge from the vagina attached to the colpostat's handles. The balloons were affixed to the colpostats with a plastic adaptor and are inserted empty. After an anterior radiograph is taken, the balloons are filled with radiological contrast material and a lateral orthogonal film is made. This lateral film taken with the balloons filled with contrast typically shows a significant posterior displacement of the anterior rectal wall away from the vaginal sources. The International Commission on Radiation Units (ICRU) rectal point is then determined 5 mm beyond the posterior boundary of the opacified balloons. We have performed 90 applications using this device, including brachytherapy applications for cervical cancer, as well as vaginal applications for endometrial carcinoma following TAH-BSO. On average, the ICRU rectal point was displaced 14 mm away from the colpostats, thus reducing the dose rate by 60% and resulting in an average dose sparing of about 1000 cGy to the anterior rectal wall.
Rosenblatt
E
E
Department of Oncology, Rambam Medical Center, Haifa, Israel.
Cederbaum
M
M
Yereslav
N
N
Kuten
A
A
D001918:Brachytherapy / Q000295:instrumentation*; D002277:Carcinoma / Q000532:radiotherapy; D002404:Catheterization / Q000295:instrumentation; D003287:Contrast Media; D003974:Diatrizoate Meglumine; D016889:Endometrial Neoplasms / Q000532:radiotherapy; D004867:Equipment Design; D005260:Female; D006801:Humans; D011859:Radiography; D011879:Radiotherapy Dosage; D012007:Rectum / Q000000981:diagnostic imaging / Q000528:radiation effects*; D002583:Uterine Cervical Neoplasms / Q000532:radiotherapy*
D003287:Contrast Media; D003974:Diatrizoate Meglumine